GW Pharma trims loss to $8 million, warns virus could hit sales

MJBizDaily
By Matt LamersMay 12, 2020, 1:04 pm218 pts
GW Pharmaceuticals lost $8 million in its latest quarter – an improvement over the previous three-month period – but the United Kingdom-based medical cannabinoid company warned the COVID-19 pandemic could hit sales if fewer patients visit their doctors. Revenue in the quarter ending March 31 reached $120.6…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Alabama Officials Release Proposed Rules for Hemp THC Products 78

Minnesota adult-use marijuana sales delayed for a predictable reason 78

Shea Coakley & Jarrod Jordan: How THC Beverages are Redefining Social Drinking 75

Revelry NYC is the Place to be for New York Cannabis Consumers 72

GOP Senator Is ‘Confident’ Psychedelics Access Will Expand Under Trump, Saying Many Veterans Speak To Him About The Benefits 66

Alpenglow Cannabis Village Lights Up Bozeman, Montana 53

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.